Prostate cancer trials in China

In China 252 Also abroad 1481

252 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Effects of Rectal Indomethacin Suppository on Postoperative CRBD in Patients Undergoing LRP
Where
Hangzhou
Age
18 years to 80 years
People
130
Run by
Zhejiang University
See details and how to joinNCT07607990
Phase 1Taking people
Study With [225Ac]Ac-FL-020 in mCRPC Participants
Where
Beijing, Shanghai
Age
18 years and over
People
50 worldwide
Run by
Full-Life Technologies UK Limited
See details and how to joinNCT06492122
Early phase 1Enrolling by invitation
A Clinical Study Evaluating the Safety and Efficacy of Local Injection of ACT#001 Chimeric Antigen Receptor T Cells in the Treatment of Castration-Resistant Prostate Cancer
Where
Hangzhou
Age
18 years and over
People
18
Run by
Zhejiang University
See details and how to joinNCT07240857
Phase 1Enrolling by invitation
YS247 (Neoantigen-Pulsed DC Vaccine) for Metastatic Prostate Cancer
Where
Shanghai
Age
18 years and over
People
18
Run by
Changhai Hospital
See details and how to joinNCT07583160
Phase 3Taking people
A Phase III Clinical Study of Rezvilutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer
Where
Beijing
Age
18 years and over
People
206
Run by
Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT07241416
Phase 2Taking people
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
Where
Changsha, Chengdu, Chongqing, Hangzhou, Hefei, Nanjing, Shanghai, Shenyang, Taiyuan, Wuhan, Xiamen, Xi'an, Zhengzhou
Age
18 years and over
People
200 worldwide
Run by
Zenith Epigenetics
See details and how to joinNCT04986423
Phase 2Taking people
SHR-1701 in Combination With Stereotactic Body Radiotherapy in mCRPC
Where
Fujian, Shanghai, Xiamen
Age
18 years to 80 years
People
66
Run by
Fudan University
See details and how to joinNCT07451795
No phaseTaking people
Theranostic Applications of Radionuclides in Prostate Cancer
Where
Guilin
Age
18 years and over
People
100
Run by
Guilin Medical University, China
See details and how to joinNCT07559201
No phaseTaking people
Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis
Where
Lanzhou, Weinan, Xi'an, Xianyang, Xining, Yan’an, Yinchuan
Age
18 years and over
People
1,000
Run by
Xijing Hospital
See details and how to joinNCT07553754
No phaseTaking people
Serial PSMA PET for Therapy Monitoring in Clinically Significant Prostate Cancer
Where
Lanzhou, Weinan, Xi'an, Xianyang, Xining, Yan’an, Yinchuan
Age
18 years and over
People
110
Run by
Xijing Hospital
See details and how to joinNCT07553780
No phaseTaking people
The Enhancement of Diagnostic and Grading Efficacy of Prostate Cancer by New MRI Sequences: A Prospective Observational Study Based on New MRI Sequences in a Single Center
Where
Suzhou
Age
20 years to 90 years
People
300
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT07552285
Phase 1/2Taking people
A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate Cancer
Where
Chengdu, Tianjin
Age
18 years to 85 years
People
100
Run by
Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT07407283
Phase 1Taking people
3D1015 Injection for Patients With mCRPC
Where
Wuxi
Age
18 years and over
People
8
Run by
Chunjing Yu
See details and how to joinNCT07537010
No phaseTaking people
Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Prostate Cancer
Where
Lanzhou, Weinan, Xi'an, Xianyang, Xining, Yan’an, Yinchuan
Age
18 years and over
People
1,000
Run by
Xijing Hospital
See details and how to joinNCT07531329
Phase 1/2Taking people
Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors
Where
Shenzhen
Age
18 years to 75 years
People
72
Run by
Beijing Biotech
See details and how to joinNCT07523529
Phase 1/2Taking people
A Study of MHB048C in Patients With Advanced Solid Tumors
Where
Shanghai
Age
18 years and over
People
200
Run by
Minghui Pharmaceutical (Hangzhou) Ltd
See details and how to joinNCT07192120
Phase 1Taking people
TSL2109 Capsules in Advanced Solid Tumor Patients: Safety, Tolerability, PK and Preliminary Efficacy
Where
Shanghai
Age
18 years and over
People
78
Run by
Tasly Pharmaceutical Group Co., Ltd
See details and how to joinNCT07514065
Phase 1/2Taking people
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
Where
Changchun, Changsha, Chengdu, Nanjing, Shanghai, Shenyang, Wuxi, Zhengzhou
Age
18 years and over
People
1,000 worldwide
Run by
DualityBio Inc.
See details and how to joinNCT05785741
No phaseTaking people
Real-world Use of Lutetium (177Lu) Vipivotide Tetraxetan in China(PSMAreal CN)
Where
Shanghai
Age
18 years to 99 years
People
170
Run by
Novartis Pharmaceuticals
See details and how to joinNCT07290270
Phase 2Taking people
Exploration of Treatment Effect of Novel Hormone Therapy Combined With Local Treatment Based on PSMA PET/CT Evaluation in mHSCP Patients
Where
Shanghai
Age
18 years and over
People
192
Run by
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT06832774
No phaseTaking people
Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer
Where
Lanzhou, Weinan, Xi'an, Xianyang, Xining, Yan’an, Yinchuan
Age
18 years and over
People
1,700 worldwide
Run by
Xijing Hospital
See details and how to joinNCT07492927
Phase 2Not yet taking people in China
Rezvilutamide With Radical Prostatectomy and Metastasis-Directed Therapy in Oligometastatic Prostate Cancer
Where
Shanghai
Age
18 years and over
People
300
Run by
Fudan University
See details and how to joinNCT07490210
No phaseNot yet taking people in China
A Phase II Clinical Two-Stage Study of Transcranial Magnetic Stimulation in Preventing Postoperative Delirium in Elderly Patients After Urological Surgery
Where
Hangzhou
Age
60 years and over
People
220
Run by
Zhejiang University
See details and how to joinNCT07480044
Phase 2Not yet taking people in China
Darolutamide ± ADT as Neoadjuvant Therapy in High-Risk/Very High-Risk Localized Prostate Cancer
Where
Beijing
Age
18 years to 80 years
People
60
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07476677
No phaseTaking people
A Multicenter, Prospective Study on the Prognostic Value of PSMA PET in Patients With Newly Diagnosed, Treatment-naïve Prostate Cancer
Where
Lanzhou, Weinan, Xi'an, Xianyang, Xining, Yan’an, Yinchuan
Age
18 years to 100 years
People
1,000
Run by
Xijing Hospital
See details and how to joinNCT07474142